In metabolic diseases, Noren Hooten et al. (57) hypothesized that alterations of the levels of DICER1 gene may play an important role in organismal aging and the upregulation of expression of DICER1 gene may provide us a new pharmacotherapeutic approaches for age-related disease, such as T2DM. This evidence concerns the gene DICER1 and type 2 diabetes mellitus.